Umhlaza wesibindi lelinye lawona mathumba ayingozi axhaphakileyo ehlabathini

708 amagama | Igqityelwe ukuvuselelwa: 2023-12-12 | By UGqr Aaron Chen
Dr. Aaron Chen - author
Umbhali: UGqr Aaron Chen
UGqr Aaron Chen yingcali yenzululwazi yezonyango kunye ne-12 + iminyaka yamava ekuxilongweni kwekliniki kunye ne-POCT. Ukhokela uphando kuvavanyo olukhawulezayo lokuyila, ukuqhuba impumelelo kwi-high-emvandelelo yegolide ye-colloidal kunye novavanyo lwe-immunofluorescence.
Liver cancer is one of the most common malignant tumors in the world
Isiqulatho

    Umhlaza wesibindi sesinye sezona zifo zixhaphakileyo emhlabeni, kwaye inani lezigulana zomhlaza wesibindi kwilizwe lam lithatha ngaphezu kwesiqingatha sehlabathi.

    Kuqikelelwa ukuba i-70 ukuya kwi-80 ipesenti yezigulane ezinomhlaza wesibindi sele sele ziphakathi okanye emva kwexesha lokuxilongwa.

    Abantu badinga kuphela malunga nekota yesibindi banokuhlangabezana neemfuno zemihla ngemihla. Ke ngoko, kwinqanaba lokuqala lomhlaza wesibindi, isibindi sisakwazi ukusebenza ngokuqhelekileyo, kwaye abantu abaziva bengakhululekanga. Ngelixa abantu beyiqaphela, isibindi sele sitshatyalalisiwe.

    Ewe kunjalo, uninzi lwee-cancer, hayi nje umhlaza wesibindi, azikhohlakali kumanqanaba abo okuqala. Ngoko ke kubaluleke kakhulu ukuphuhlisa ulwazi lokuhlolwa kwangethuba!

    Umhlaza unokuthintelwa kwaye uhlolwe kwangoko

    Ngo-2011, uMbutho wezeMpilo weHlabathi ucebise ukuba isinye-sesithathu sayo yonke imihlaza inokuthintelwa ngokupheleleyo; Isiqingatha sesithathu somhlaza sinokunyangeka ngokufunyanwa kwangoko; Isinye kwisithathu sayo yonke imihlaza, ubomi bezigulana bunokolulwa, bungabi nantlungu kwaye buphucule umgangatho wobomi ngonyango olukhoyo.

    Oku kuthetha ukuba kukho ixesha kunye nethuba lokuthatha amanyathelo okuthintela kunye nokuhlolwa kwangethuba ukuthintela okanye ukunciphisa iziganeko zobubi.

    Ubudala bokuhlola: indoda ≥40 iminyaka, ibhinqa ≥50 iminyaka; Abantu kufuneka bajongwe rhoqo kwiinyanga ezi-6.

    Ukubhaqwa kophawu lwethumbayindlela esebenza ngamandla kunye nokusetyenziswa, phakathi kwayo, ialfa- I-fetoprotein (AFP) ingasetyenziselwa ukuhlola izigulane ezisengozini enkulu yomhlaza wesibindi osisiseko.

    Yintoni i-alpha-fetoprotein?

    I-Alpha-fetoprotein (AFP) yi-acidic glycoprotein efumaneka kwigazi lomntwana ongekazalwa. Emva kokuzalwa, alpha- I-fetoprotein egazini ihla ngokukhawuleza, ibuyele kwinqanaba eliqhelekileyo phakathi kweenyanga ezimbalwa ukuya kunyaka. Umgangatho oqhelekileyo womntu uphantsi kakhulu.

    Nangona kunjalo, xa iiseli zesibindi ziba nomhlaza, ziyachacha zivelisa iprotheni, kwaye njengoko isifo siqhubela phambili, inqanaba laso kwiserum landa kakhulu.

    Ke ngoko, i-alpha-fetoprotein iye yaba sisiphawuli esithile se-tumor ekuxilongweni komhlaza wesibindi osisiseko, esinendima yokumisela ukuxilongwa, ukuxilongwa kwangoko kunye nokuxilongwa kweSichongi.

    Ukusetyenziswa kweklinikhi yealpha-fetoprotein

    Umgangatho woShishino lwezeMpilo lweRiphabhlikhi yaBantu baseTshayina ichaza ngokucacileyo ukuba:

    I-01Serum AFP idityaniswe ne-ultrasound yesibindi ingasetyenziselwa kwi-Serum AFP edityaniswe ne-ultrasonography yesibindi ingasetyenziselwa ukukhangela amaqela aphezulu - ingozi yomhlaza wesibindi sokuqala.

    I-02Serum AFP yeyona nto isetyenziswa kakhulu umakisha ithumba kuxilongo lwezonyango lweprimary hepatocellular carcinoma (HCC).

    I-03I-serum AFP≥400μg / L ngaphezu kwenyanga ye-1, okanye ≥200μg / L kwiinyanga ze-2, umhlaza wesibindi kufuneka ukrokrelwe kakhulu emva kokuba ungabandakanyi ukukhulelwa, isifo sesibindi esisebenzayo kunye ne-embryo-i-tumor efunyenwe kwi-germ line. B-uvavanyo lwe-ultrasound, i-CT/MRI kunye ne-biopsy kufuneka zenziwe xa kuyimfuneko ukuqinisekisa ukuxilongwa.

    I-04Serum AFP luphawu olubalulekileyo lokugweba i-prognosis yomhlaza wesibindi sokuqala. Uxinzelelo oluphezulu lwe-SERUM AFP lubonisa ukuxilonga okungalunganga.

    I-05Serum AFP ingasetyenziselwa ukulandelela kunye nokuphindaphinda ukujonga izigulane ezinomhlaza wesibindi emva kokuhlinzwa okanye ukutshintshwa kwesibindi. Kufuneka ivavanywe rhoqo kwiinyanga ezi-3 kwiminyaka emi-2 emva kotyando kunye neenyanga ezi-6 kwisithuba seminyaka emi-3 ukuya kwemi-5.

    Ingaba isihlwele somhlaza wesibindi esisemngciphekweni omkhulu sibandakanya ntoni?

    Usulelwe yintsholongwane ye-hepatitis B (HBV) kunye / okanye i-virus ye-hepatitis C (HCV); Ukusela kakhulu;

    i-steatohepatitis engeyiyo utywala;

    Ukusetyenziswa kwexesha elide lokutya okungcoliswe yi-aflatoxins; i-cirrhosis ngenxa yezizathu ezahlukeneyo;
    Imbali yosapho yomhlaza wesibindi.

    I-Hangzhou Laihe Biotech Co., Ltd I-AFP assay reagents (i-fluorescence immunochromatography) isetyenziselwa ukumisela ubungakanani be-AFP kwi-serum yabantu okanye iisampulu zeplasma kwi-vitro. Isetyenziselwa ikakhulu ukubeka iliso okuguquguqukayo kwezigulane ezinomhlaza wethumba ukuncedisa ekugwebeni inkqubo yesifo okanye umphumo wonyango.

    Esi sikhuseli samkela indlela yesandwich ephindwe kabini ye-antibody. Indawo yovavanyo (T) yekhithi iqulathe i-alpha-fetoprotein monoclonal antibody, indawo yolawulo lomgangatho (C) iqulethe i-anti-rabbit IgG yeegusha, kwaye isithinteli sokubhaqa sineempawu ze-fluorescent ze-alpha-fetoprotein monoclonal antibody kunye ne-Rabbit IgG.

    Uhlobo lwesampula: i-serum kunye neplasma
    Ixesha elifutshane lokufumanisa: I-12min ingabonisa iziphumo
    Uluhlu olubanzi lomgca: 5-350ng/mL
    Umahluko webhetshi: ≤10%
    Umahluko phakathi kweebhetshi: ≤10%

    Ukusebenza kwemveliso okuzinzileyo: ukutenxa ngokunxulumene ≤10%
    Ubungakanani besampuli: 75μL serum / plasma
    Kulula ukusebenza (inyathelo elinye emva kokongeza isampuli)
    Ukubona umda: 5.0ng/mL

    Alpha-fetoprotein (AFP) reagent

    Alpha-fetoprotein (AFP) reagent (Fluorescence immunochromatography)


    Ixesha leposi:Mar-17-2022